Marsh & McLennan Companies, Inc.

MRSHNYSECIK 62709Financial / Insurance Brokersfiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$6.9B
+8.1% on Q3 FY2025
Net income
$808M
+8.2% on Q3 FY2025
Free cash flow
$1.4B
−30.5% on Q3 FY2025
Diluted EPS
$1.69
+11.9% on Q3 FY2025
Revenue, TTM
$28.5B
trailing four quarters
Net margin, TTM
14.2%
net income $4.0B
Free cash flow, TTM
$4.2B
$4.5B less $320M capex
Cash and equivalents
$1.8B
long-term debt $18.9B, Sep 30, 2026
Shares, 12-month change
−2.9%
476M shares, Sep 30, 2026
Buybacks, TTM
$3.0B
3.1% of market value
Dividends, TTM
$1.8B
1.8% of market value
Market value
$98.8B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 15, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Marsh & McLennan Companies, Inc. reported revenue of $6.9B, +8.1% on Q3 FY2025, and net income of $808M (+8.2%). Operating margin was 17.7%. Free cash flow, operating cash flow less capital expenditures, was $1.4B ($1.5B less $81M). Diluted earnings per share were $1.69.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

MRSH daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $207.72 · H $209.89 · L $206.76 · C $207.78 · +1.02% on the dayOver the range: +13.02%, Nov 14, 2025 to Nov 13, 2026
$153$169$185$201$217Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 15, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6B$8BQ4'22, Revenue: $5.0BQ4'22, Net income: $466MQ4'22Q1'23, Revenue: $5.9BQ1'23, Net income: $1.2BQ1'23Q2'23, Revenue: $5.9BQ2'23, Net income: $1.0BQ2'23Q3'23, Revenue: $5.4BQ3'23, Net income: $730MQ3'23Q4'23, Revenue: $5.6BQ4'23, Net income: $756MQ4'23Q1'24, Revenue: $6.5BQ1'24, Net income: $1.4BQ1'24Q2'24, Revenue: $6.2BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $5.7BQ3'24, Net income: $747MQ3'24Q4'24, Revenue: $6.1BQ4'24, Net income: $788MQ4'24Q1'25, Revenue: $7.1BQ1'25, Net income: $1.4BQ1'25Q2'25, Revenue: $7.0BQ2'25, Net income: $1.2BQ2'25Q3'25, Revenue: $6.4BQ3'25, Net income: $747MQ3'25Q4'25, Revenue: $6.6BQ4'25, Net income: $821MQ4'25Q1'26, Revenue: $7.6BQ1'26, Net income: $1.1BQ1'26Q2'26, Revenue: $7.4BQ2'26, Net income: $1.3BQ2'26Q3'26, Revenue: $6.9BQ3'26, Net income: $808MQ3'26$0$2B$4B$6B$8BQ4'22, Revenue: $5.0BQ4'22, Net income: $466MQ4'22Q1'23, Revenue: $5.9BQ1'23, Net income: $1.2BQ1'23Q2'23, Revenue: $5.9BQ2'23, Net income: $1.0BQ2'23Q3'23, Revenue: $5.4BQ3'23, Net income: $730MQ3'23Q4'23, Revenue: $5.6BQ4'23, Net income: $756MQ4'23Q1'24, Revenue: $6.5BQ1'24, Net income: $1.4BQ1'24Q2'24, Revenue: $6.2BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $5.7BQ3'24, Net income: $747MQ3'24Q4'24, Revenue: $6.1BQ4'24, Net income: $788MQ4'24Q1'25, Revenue: $7.1BQ1'25, Net income: $1.4BQ1'25Q2'25, Revenue: $7.0BQ2'25, Net income: $1.2BQ2'25Q3'25, Revenue: $6.4BQ3'25, Net income: $747MQ3'25Q4'25, Revenue: $6.6BQ4'25, Net income: $821MQ4'25Q1'26, Revenue: $7.6BQ1'26, Net income: $1.1BQ1'26Q2'26, Revenue: $7.4BQ2'26, Net income: $1.3BQ2'26Q3'26, Revenue: $6.9BQ3'26, Net income: $808MQ3'26$0$2B$4B$6B$8BQ4'22, Revenue: $5.0BQ4'22, Net income: $466MQ1'23, Revenue: $5.9BQ1'23, Net income: $1.2BQ1'23Q2'23, Revenue: $5.9BQ2'23, Net income: $1.0BQ3'23, Revenue: $5.4BQ3'23, Net income: $730MQ3'23Q4'23, Revenue: $5.6BQ4'23, Net income: $756MQ1'24, Revenue: $6.5BQ1'24, Net income: $1.4BQ1'24Q2'24, Revenue: $6.2BQ2'24, Net income: $1.1BQ3'24, Revenue: $5.7BQ3'24, Net income: $747MQ3'24Q4'24, Revenue: $6.1BQ4'24, Net income: $788MQ1'25, Revenue: $7.1BQ1'25, Net income: $1.4BQ1'25Q2'25, Revenue: $7.0BQ2'25, Net income: $1.2BQ3'25, Revenue: $6.4BQ3'25, Net income: $747MQ3'25Q4'25, Revenue: $6.6BQ4'25, Net income: $821MQ1'26, Revenue: $7.6BQ1'26, Net income: $1.1BQ1'26Q2'26, Revenue: $7.4BQ2'26, Net income: $1.3BQ3'26, Revenue: $6.9BQ3'26, Net income: $808MQ3'26

Net income losses drawn in red.

Free cash flow
−$1B$0$1B$2B$3BQ4'22, Free cash flow: $1.4BQ4'22Q1'23, Free cash flow: −$903MQ1'23Q2'23, Free cash flow: $1.4BQ2'23Q3'23, Free cash flow: $1.7BQ3'23Q4'23, Free cash flow: $1.7BQ4'23Q1'24, Free cash flow: −$868MQ1'24Q2'24, Free cash flow: $1.1BQ2'24Q3'24, Free cash flow: $1.8BQ3'24Q4'24, Free cash flow: $1.9BQ4'24Q1'25, Free cash flow: −$677MQ1'25Q2'25, Free cash flow: $1.6BQ2'25Q3'25, Free cash flow: $2.0BQ3'25Q4'25, Free cash flow: $2.1BQ4'25Q1'26, Free cash flow: −$750MQ1'26Q2'26, Free cash flow: $1.5BQ2'26Q3'26, Free cash flow: $1.4BQ3'26−$1B$0$1B$2B$3BQ4'22, Free cash flow: $1.4BQ4'22Q1'23, Free cash flow: −$903MQ1'23Q2'23, Free cash flow: $1.4BQ2'23Q3'23, Free cash flow: $1.7BQ3'23Q4'23, Free cash flow: $1.7BQ4'23Q1'24, Free cash flow: −$868MQ1'24Q2'24, Free cash flow: $1.1BQ2'24Q3'24, Free cash flow: $1.8BQ3'24Q4'24, Free cash flow: $1.9BQ4'24Q1'25, Free cash flow: −$677MQ1'25Q2'25, Free cash flow: $1.6BQ2'25Q3'25, Free cash flow: $2.0BQ3'25Q4'25, Free cash flow: $2.1BQ4'25Q1'26, Free cash flow: −$750MQ1'26Q2'26, Free cash flow: $1.5BQ2'26Q3'26, Free cash flow: $1.4BQ3'26−$1B$0$1B$2B$3BQ4'22, Free cash flow: $1.4BQ1'23, Free cash flow: −$903MQ1'23Q2'23, Free cash flow: $1.4BQ3'23, Free cash flow: $1.7BQ3'23Q4'23, Free cash flow: $1.7BQ1'24, Free cash flow: −$868MQ1'24Q2'24, Free cash flow: $1.1BQ3'24, Free cash flow: $1.8BQ3'24Q4'24, Free cash flow: $1.9BQ1'25, Free cash flow: −$677MQ1'25Q2'25, Free cash flow: $1.6BQ3'25, Free cash flow: $2.0BQ3'25Q4'25, Free cash flow: $2.1BQ1'26, Free cash flow: −$750MQ1'26Q2'26, Free cash flow: $1.5BQ3'26, Free cash flow: $1.4BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $1.4BQ4'22, Long-term debt: $11.2BQ4'22Q1'23, Cash and equivalents: $1.0BQ1'23, Long-term debt: $10.8BQ1'23Q2'23, Cash and equivalents: $1.2BQ2'23, Long-term debt: $10.2BQ2'23Q3'23, Cash and equivalents: $2.9BQ3'23, Long-term debt: $11.8BQ3'23Q4'23, Cash and equivalents: $3.4BQ4'23, Long-term debt: $11.8BQ4'23Q1'24, Cash and equivalents: $1.5BQ1'24, Long-term debt: $12.3BQ1'24Q2'24, Cash and equivalents: $1.7BQ2'24, Long-term debt: $12.3BQ2'24Q3'24, Cash and equivalents: $1.8BQ3'24, Long-term debt: $12.3BQ3'24Q4'24, Cash and equivalents: $2.4BQ4'24, Long-term debt: $19.4BQ4'24Q1'25, Cash and equivalents: $1.6BQ1'25, Long-term debt: $18.9BQ1'25Q2'25, Cash and equivalents: $1.7BQ2'25, Long-term debt: $19.0BQ2'25Q3'25, Cash and equivalents: $2.5BQ3'25, Long-term debt: $18.3BQ3'25Q4'25, Cash and equivalents: $2.7BQ4'25, Long-term debt: $18.3BQ4'25Q1'26, Cash and equivalents: $1.6BQ1'26, Long-term debt: $18.9BQ1'26Q2'26, Cash and equivalents: $1.7BQ2'26, Long-term debt: $18.9BQ2'26Q3'26, Cash and equivalents: $1.8BQ3'26, Long-term debt: $18.9BQ3'26$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $1.4BQ4'22, Long-term debt: $11.2BQ4'22Q1'23, Cash and equivalents: $1.0BQ1'23, Long-term debt: $10.8BQ1'23Q2'23, Cash and equivalents: $1.2BQ2'23, Long-term debt: $10.2BQ2'23Q3'23, Cash and equivalents: $2.9BQ3'23, Long-term debt: $11.8BQ3'23Q4'23, Cash and equivalents: $3.4BQ4'23, Long-term debt: $11.8BQ4'23Q1'24, Cash and equivalents: $1.5BQ1'24, Long-term debt: $12.3BQ1'24Q2'24, Cash and equivalents: $1.7BQ2'24, Long-term debt: $12.3BQ2'24Q3'24, Cash and equivalents: $1.8BQ3'24, Long-term debt: $12.3BQ3'24Q4'24, Cash and equivalents: $2.4BQ4'24, Long-term debt: $19.4BQ4'24Q1'25, Cash and equivalents: $1.6BQ1'25, Long-term debt: $18.9BQ1'25Q2'25, Cash and equivalents: $1.7BQ2'25, Long-term debt: $19.0BQ2'25Q3'25, Cash and equivalents: $2.5BQ3'25, Long-term debt: $18.3BQ3'25Q4'25, Cash and equivalents: $2.7BQ4'25, Long-term debt: $18.3BQ4'25Q1'26, Cash and equivalents: $1.6BQ1'26, Long-term debt: $18.9BQ1'26Q2'26, Cash and equivalents: $1.7BQ2'26, Long-term debt: $18.9BQ2'26Q3'26, Cash and equivalents: $1.8BQ3'26, Long-term debt: $18.9BQ3'26$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $1.4BQ4'22, Long-term debt: $11.2BQ1'23, Cash and equivalents: $1.0BQ1'23, Long-term debt: $10.8BQ1'23Q2'23, Cash and equivalents: $1.2BQ2'23, Long-term debt: $10.2BQ3'23, Cash and equivalents: $2.9BQ3'23, Long-term debt: $11.8BQ3'23Q4'23, Cash and equivalents: $3.4BQ4'23, Long-term debt: $11.8BQ1'24, Cash and equivalents: $1.5BQ1'24, Long-term debt: $12.3BQ1'24Q2'24, Cash and equivalents: $1.7BQ2'24, Long-term debt: $12.3BQ3'24, Cash and equivalents: $1.8BQ3'24, Long-term debt: $12.3BQ3'24Q4'24, Cash and equivalents: $2.4BQ4'24, Long-term debt: $19.4BQ1'25, Cash and equivalents: $1.6BQ1'25, Long-term debt: $18.9BQ1'25Q2'25, Cash and equivalents: $1.7BQ2'25, Long-term debt: $19.0BQ3'25, Cash and equivalents: $2.5BQ3'25, Long-term debt: $18.3BQ3'25Q4'25, Cash and equivalents: $2.7BQ4'25, Long-term debt: $18.3BQ1'26, Cash and equivalents: $1.6BQ1'26, Long-term debt: $18.9BQ1'26Q2'26, Cash and equivalents: $1.7BQ2'26, Long-term debt: $18.9BQ3'26, Cash and equivalents: $1.8BQ3'26, Long-term debt: $18.9BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 15, 2026.

Marsh & McLennan Companies, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 15, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 16, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 16, 2025Q2 FY2025ended Jun 30, 2025filed Jul 17, 2025Q1 FY2025ended Mar 31, 2025filed Apr 17, 2025Q4 FY2024ended Dec 31, 2024filed Feb 10, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue6,8637,4047,5976,5956,3516,9747,0616,067+8.1%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income1,2151,8991,7541,2191,1701,8292,0051,142+3.8%
Other income (expense)—————————
Pretax income1,0331,7021,5811,0561,0101,6461,8271,009+2.3%
Income tax221411395222253415415208−12.6%
Net income8081,2661,1468217471,2111,381788+8.2%
Diluted EPS ($)1.692.632.36—1.512.452.79—+11.9%
Diluted shares (millions)479482486—494495495——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 15, 2026.

Marsh & McLennan Companies, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 15, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 16, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 16, 2025Q2 FY2025ended Jun 30, 2025filed Jul 17, 2025Q1 FY2025ended Mar 31, 2025filed Apr 17, 2025Q4 FY2024ended Dec 31, 2024filed Feb 10, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents1,8421,7001,6112,6872,5111,6771,6042,398−26.6%
Short-term investments—————————
Total current assets24,10724,33323,23623,20023,69923,33422,46122,117+1.7%
Total assets59,80659,68258,55258,71058,78358,55557,01556,481+1.7%
Total current liabilities22,10921,35920,90521,06021,09819,40019,77519,518+4.8%
Long-term debt18,88918,89118,90018,32018,31718,96018,86219,428+3.1%
Total debt20,53320,56120,60219,58719,58019,72920,52919,947+4.9%
Total liabilities—————————
Stockholders’ equity—————————
Shares outstanding (millions)476477482484490492493491—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 15, 2026.

Marsh & McLennan Companies, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 15, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 16, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 16, 2025Q2 FY2025ended Jun 30, 2025filed Jul 17, 2025Q1 FY2025ended Mar 31, 2025filed Apr 17, 2025Q4 FY2024ended Dec 31, 2024filed Feb 10, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow1,4781,523(688)2,1612,0821,671(622)1,956−29.0%
Capital expenditures81726210572595576+12.5%
Free cash flow (CFO − capex)1,3971,451(750)2,0562,0101,612(677)1,880−30.5%
Depreciation and amortization8990899191918893−2.2%
Share repurchases5047577551,0104023003000+25.4%
Dividends paid476438440444445405405403+7.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 9, 2026.

Income statement

Marsh & McLennan Companies, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 10, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 17, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 10, 2009FY2007ended Dec 31, 2007filed Aug 10, 2009
Revenue26,98124,45822,73620,72019,82017,22416,65214,95014,02413,21112,89312,95112,26111,92411,52610,5509,83110,73011,135
Cost of revenue———————————————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative———————————————————
Operating income6,2235,8175,2824,2804,3123,0662,6772,7612,6552,4312,4192,3012,0771,8291,638939778679854
Other income (expense)——————22—15138376924943(2)(12)173
Pretax income5,5395,4805,0264,0824,2082,7932,4392,2442,6432,4802,3072,0571,9731,6961,404769552494—
Income tax1,3051,3631,2249951,0347476665741,13368567158659449242220421113298
Net income4,1604,0603,7563,0503,1432,0161,7421,6501,4921,7681,5991,4651,3571,176993855227(73)2,475
Diluted EPS ($)8.438.187.536.046.133.943.413.232.873.382.982.652.432.131.791.550.42(0.14)4.45
Diluted shares (millions)494496499505513512511511519524536553558552551544524515542

Balance sheet

Marsh & McLennan Companies, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 10, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 17, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 10, 2009FY2007ended Dec 31, 2007filed Aug 10, 2009
Cash and equivalents2,6872,3983,3581,4421,7522,0891,1551,0661,2051,0261,3741,9582,3032,3012,1131,8941,7771,6852,133
Short-term investments—————————————414330610302——
Total current assets23,20022,11721,74818,9598,2648,1557,0685,9345,5624,8845,0445,5336,3005,9635,6485,2764,9314,784—
Total assets58,71056,48148,03044,11444,01033,04931,35721,57820,42918,19018,21617,79316,96016,28815,45415,31015,33715,206—
Total current liabilities21,06019,51819,79517,8326,6546,5566,6794,9244,2624,0823,7083,6773,8093,5643,7393,1053,7153,386—
Long-term debt18,32019,42811,84411,22710,93310,79610,7415,510———3,368———————
Total debt19,58719,94713,46311,76310,96711,83013,1716,1385,2254,5454,4023,3682,6212,9182,9283,0343,5923,602—
Total liabilities———————————————————
Stockholders’ equity———————————————————
Shares outstanding (millions)484491492495503508504505508515521539548548543544532——

Cash flow statement

Marsh & McLennan Companies, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 10, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 17, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 10, 2009FY2007ended Dec 31, 2007filed Aug 10, 2009
Operating cash flow5,2924,3024,2583,4653,5163,3822,3612,4281,8932,0071,8882,1191,3411,3221,705722640940(303)
Capital expenditures291316416470406348421314302253325368401320280271305386378
Free cash flow (CFO − capex)5,0013,9863,8422,9953,1103,0341,9402,1141,5911,7541,5631,7519401,0021,425451335554(681)
Depreciation and amortization361369370381747741647494481438423388358349332357365404442
Share repurchases2,0129001,1501,9501,15904856759008001,4008005502303618633391,309
Dividends paid1,6991,5131,2981,1381,026943890807740682632582533497480452431412413

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$5M
5 sales by 5 insiders; officers and directors $5M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$20M
14 sales by 9 insiders; officers and directors $20M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 5, 2026Beswick PaulSVP, Chief Information Officeropen-market sale10b5-1713$212.77$152K15,663Nov 9, 2026
Nov 2, 2026Tomlinson PatrickPres/CEO, Marsh People & Invoption exercise2,500$83.05$208K6,756Nov 4, 2026
Nov 2, 2026Tomlinson PatrickPres/CEO, Marsh People & Invtax withholding1,775$203.47$361K4,981Nov 4, 2026
Oct 23, 2026Klisura Dean MichaelPresident & CEO, Marsh REopen-market sale10b5-14,194$200.00$839K20,935Oct 26, 2026
Oct 23, 2026Mills StacyVice President and Controlleropen-market sale10b5-11,215$200.00$243K2,705Oct 26, 2026
Sep 2, 2026Brennan KatherineSVP and General Counseloption exercise1,197$83.05$99K8,527Sep 3, 2026
Sep 2, 2026Brennan KatherineSVP and General Counselopen-market sale1,197$187.90$225K7,330Sep 3, 2026
Sep 2, 2026Doyle John QPresident and CEOoption exercise16,656$73.19$1M133,467Sep 3, 2026
Sep 2, 2026Doyle John QPresident and CEOopen-market sale10b5-116,656$188.51$3M116,811Sep 3, 2026
Aug 15, 2026Mills Steven ADirectoraward194$188.44$37K5,952Aug 18, 2026
Aug 15, 2026Broussard Bruce DDirectoraward192$188.44$36K1,617Aug 18, 2026
Aug 6, 2026Jones John JudeChief Marketing Officeropen-market sale6,500$191.96$1M1,478Aug 7, 2026
Jul 29, 2026Beswick PaulSVP, Chief Information Officeropen-market sale10b5-1713$198.00$141K16,376Jul 31, 2026
Jul 28, 2026South MartinChief Client Officeropen-market sale7,100$189.99$1M16,632Jul 29, 2026
Jul 23, 2026Yates Lloyd MDirectoropen-market sale12,000$175.65$2M12,001Jul 24, 2026
Jun 2, 2026Doyle John QPresident and CEOoption exercise16,656$73.19$1M133,467Jun 3, 2026
Jun 2, 2026Doyle John QPresident and CEOopen-market sale10b5-116,656$161.71$3M116,811Jun 3, 2026
Jun 1, 2026Mills Steven ADirectoraward1,349$159.28$215K5,758Jun 3, 2026
Jun 1, 2026Hanway H EdwardDirectoraward1,349$159.28$215K36,868Jun 3, 2026
Jun 1, 2026Hartmann JudithDirectoraward1,349$159.28$215K4,323Jun 3, 2026
Jun 1, 2026Harrison PeterDirectoraward1,350$159.28$215K1,350Jun 3, 2026
Jun 1, 2026Harrison PeterDirectortax withholding103$159.28$16K1,246Jun 3, 2026
Jun 1, 2026Broussard Bruce DDirectoraward1,349$159.28$215K1,425Jun 3, 2026
May 15, 2026Mills Steven ADirectoraward264$160.60$42K4,409May 18, 2026
Mar 15, 2026Tomlinson PatrickPresident and CEO, Mercertax withholding627$172.15$108K4,256Mar 17, 2026

Full insider history for Marsh & McLennan Companies, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held MRSH in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MRSH by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$8M46,3000.01%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
MARSH & MCLENNAN COMPANIES, INC., CIK 62709 on EDGAR
Extract generated
November 16, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: operating income FY2016
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, RevenueFromContractWithCustomerIncludingAssessedTax, SalesRevenueServicesNet
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: OperatingIncomeLoss
Other income (expense): InvestmentIncomeNonoperating
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total debt: LongTermDebt, LongTermDebt+short-term, with finance leases, with finance leases+short-term
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/MRSH.json